Tenofovir Gel Wins Out In Drug Absorption Study, But HIV Prevention Trials Say Differently

A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations of active drug in vaginal tissue than the oral tablet, suggesting that tenofovir gel should be highly effective in protecting women against HIV transmitted through vaginal sex...

Source: Health News from Medical News Today - February 1, 2013 Category: Consumer Health News Tags: HIV / AIDS Source Type: news